QHL-1231

N/A

Report date: 2023/12/27 10:01:59
NME

Base Information

Drug NameQHL-1231
Drug Alias NameQHL-1231
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase modulatorsVascular endothelial growth factor modulatorsHepatocyte growth factor receptor modulators
TargetsHepatocyte growth factor receptorAXL receptor tyrosine kinaseVascular endothelial growth factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Affinity Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Affinity Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A